As we prepare to gather with family and friends around tables big and small, it’s time to ask the age old question: What are you thankful for this year? Many of us will mention we are thankful for our health, but chances are that few will express thanks for the scientific research and public health vigilance that play a pivotal role in health and health care. In 1918, a major flu pandemic took the lives of 675,000 Americans and 50 million people across the globe. Today, vaccination and medicines that reduce the effects of the flu have dramatically reduced its impact. Looking ahead, researchers are making progress toward a “universal” flu vaccine that crosses all strains of flu and provides...

Dear Research Advocate, On the Monday before Thanksgiving each year, Research!America, along with public health leaders across the nation take time to salute the people who work day-in and day-out to protect us from disease, injury, and other threats to our nation’s health. Members of this critical workforce can be found in every community across the country. They track infectious diseases and administer the vaccines to prevent their spread. They warn us about overuse of antibiotics leading to drug-resistant infections. They educate us about preventing accidental deaths by using infant car seats and about newer but avoidable dangers like vaping. And more. The public health workforce...

Thyroid eye disease is a serious, debilitating, and vision-threatening autoimmune disease where the immune system attacks muscles and other tissue behind and around the eyes, which can result in potentially sight-threatening proptosis (eye bulging). Symptoms include light sensitivity, bulging eyes, double vision, and red, watery, and irritated eyes. People living with thyroid eye disease frequently experience long-term reduced quality of life, including an inability to work and carry out many other day-to-day activities At a recent briefing held by the National Alliance for Eye and Vision Research (NAEVR), a Research!America alliance member, patient Christine Gustafson shared a common...

Dear Research Advocate, With new rumors surfacing daily, it’s difficult to gauge the odds of Congress and the Trump Administration completing FY20 appropriations this calendar year. We are now anticipating another short-term CR that will flat-fund government into December, buying a bit more time for final negotiations. If those negotiations fail, the options become yet another CR or a government shutdown. None of these scenarios serves the public interest. Imagine if federal agencies couldn’t adjust spending to jettison what is not working and invest in what is. Imagine if there were resources to seed the kind of medical and public health progress that saves lives, yet those resources lie...